MONOCLONAL ANTI-ALPHA-AMILASE-ANTIBODY, OBTAINING PROCESS AND REAMEDY FOR DIABETIS MELLITUS

The present invention provides a monoclonal anti-alpha-amylase antibody which non-specifically inhibits the enzyme activity of human alpha-amylase by more than 90%. The present invention also provides a process for obtaining this monoclonal antibody and a medicament containing it.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KURUTO BUARUTAA NAUYOOKUSU, MARUCHIN GERUBAA
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides a monoclonal anti-alpha-amylase antibody which non-specifically inhibits the enzyme activity of human alpha-amylase by more than 90%. The present invention also provides a process for obtaining this monoclonal antibody and a medicament containing it.